Strategic Growth Clinisys recently expanded its lab informatics footprint through an acquisition of Orchard Software in July 2025, signaling rapid growth and a broader product portfolio that can unlock cross-sell opportunities to existing customers and attract new labs across sectors.

Global Reach With over 7,000 labs in 42 countries and offices across North America, Europe, and Asia, there are ample regional sales opportunities, channel partnerships, and localized deployment services to target large, multinational lab networks and public health initiatives.

AI and Automation Recent product updates and partnerships around governed AI assistants and low-code/no-code LIMS configurations indicate a focus on automation and user-friendly customization, enabling upsell to labs seeking faster deployment, reduced IT burden, and smarter decision support.

Healthcare Partnerships Active collaborations with NHS Trusts, hospitals, and health organizations, plus integrations with healthcare platforms, suggest a strong foothold for expanding within clinical lab networks and secure data exchange, driving opportunities for CLS CARE expansion and analytics offerings.

Data & Compliance A robust informatics platform used across regulated industries (healthcare, water, environmental sciences, toxicology, and food & beverage) creates cross-domain selling angles for compliance-driven features, governance capabilities, and scalable cloud deployments to meet evolving regulatory requirements.